Transcutaneous Electrical Nerve Stimulation for Early Pain Control in Temporomandibular Disorders
Ranscutaneous Electrical Nerve Stimulation As An Adjunct To Standard Conservative Therapy For Early Pain Control In Temporomandibular Disorders: A Controlled Clinical Trial
1 other identifier
interventional
48
1 country
1
Brief Summary
To evaluate whether adding conventional transcutaneous electrical nerve stimulation (TENS) to a standard conservative regimen (patient education, pharmacotherapy, and a home exercise programme) provides additional short- and medium-term benefit for pain, mandibular function, and quality of life in patients with temporomandibular disorders (TMD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2011
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 28, 2026
CompletedFirst Posted
Study publicly available on registry
August 4, 2026
CompletedAugust 4, 2026
July 1, 2026
2.1 years
July 28, 2026
July 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain at rest assessed by Visual Analog Scale (VAS)
Pain intensity at rest will be evaluated using a 10-cm Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores represent worse outcome/greater pain intensity.
Baseline, week 2 (immediately post-treatment), and week 12 (3 months follow-up)
Secondary Outcomes (3)
Pain during jaw function assessed by Visual Analog Scale (VAS)
Baseline, week 2 (immediately post-treatment), and week 12 (3 months follow-up)
Temporomandibular joint dysfunction assessed by the Modified Helkimo Clinical Dysfunction Index
Baseline, week 2 (immediately post-treatment), and week 12 (3 months follow-up)
Mandibular range of motion measured in millimeters using a digital caliper
Baseline, week 2 (immediately post-treatment), and week 12 (3 months follow-up)
Study Arms (2)
TENS Group
EXPERIMENTALPatients received conventional TENS (100 Hz, 200 µs, sensory-level, 30 min/session, 5 sessions/week for 2 weeks) in addition to a standard conservative regimen consisting of patient education, pharmacotherapy, and a home exercise programme
Control Group
ACTIVE COMPARATORPatients received a standard conservative regimen alone, consisting of patient education, a two-week pharmacological course of dexketoprofen (50 mg/day) plus thiocolchicoside (16 mg/day), and a standardised home exercise programme. No TENS was applied.
Interventions
Patient education about the resting position of the tongue and mandible and avoidance of parafunctional habits; a two-week pharmacological regimen of dexketoprofen 50 mg/day and thiocolchicoside 16 mg/day; and a standardised home exercise programme comprising active and passive jaw range-of-motion, isometric, and postural exercises
A charge-balanced biphasic waveform with a pulse width of 200 µs, a frequency of 100 Hz, and an amplitude adjusted to produce a comfortable, non-painful paraesthesia using an Intelect® TENS device. Sessions lasted 30 minutes and were applied 5 days per week for 2 weeks (10 sessions)
Eligibility Criteria
You may qualify if:
- Patients aged between 18 and 65 years.
- Patients diagnosed with temporomandibular disorders (TMD) according to the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) Axis I.
- Patients who agreed to participate and signed the informed consent form.
You may not qualify if:
- Facial pain attributable to another condition (sinusitis, migraine, tension-type headache, trigeminal neuralgia).
- TMJ involvement secondary to an inflammatory systemic disease.
- TMJ subluxation.
- Degenerative cervical disease restricting neck movement.
- Any contraindication to TENS.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Balikesir Universitylead
- Necmettin Erbakan Universitycollaborator
Study Sites (1)
Necmettin Erbakan University
Konya, Konya, 42090, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Nilay Şahin, Prof. Dr.
Balikesir University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 28, 2026
First Posted
August 4, 2026
Study Start
April 1, 2011
Primary Completion
May 1, 2013
Study Completion
May 1, 2013
Last Updated
August 4, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share